Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Public ClinicalTrials.gov record NCT02057575. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-masked, Randomized, Controlled Study Assessing the Safety and Ocular Hypotensive Efficacy of PG324 Ophthalmic Solution, 0.01% and PG324 Ophthalmic Solution, 0.02%, Compared to AR-13324 Ophthalmic Solution, 0.02% and Latanoprost Ophthalmic Solution, 0.005% in Patients With Elevated Intraocular Pressure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the ocular hypotensive efficacy of PG324 ophthalmic solution relative to its individual components in patients with open angle glaucoma or ocular hypertension.
Study identification
- NCT ID
- NCT02057575
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 298 participants
Conditions and interventions
Conditions
Interventions
- PG324 Ophthalmic Solution 0.01% Drug
- PG324 Ophthalmic Solution 0.02% Drug
- Netarsudil (AR-13324) Ophthalmic Solution 0.02% Drug
- Latanoprost Ophthalmic Solution 0.005% Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2014 (Type not available)
- Primary completion
- Jun 2014 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- Jun 4, 2019
2014
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kenneth Sall, M.D. | Artesia | California | 90701 | — |
| United Medical Research Institute | Inglewood | California | 90301 | — |
| Aesthetic Eye Care Institute | Newport Beach | California | 92657 | — |
| Bacharach practice | Petaluma | California | 94954 | — |
| Centre For Health Care | Poway | California | 92064 | — |
| Clayton Eye Center | Morrow | Georgia | 30260 | — |
| Coastal Research Associates, LLC | Roswell | Georgia | 30076 | — |
| Bradley Kwapiszeski, MD | Shawnee Mission | Kansas | 66204 | — |
| Taustine Eye Center | Louisville | Kentucky | 40217 | — |
| Seidenberg Protzko Eye Associates | Havre de Grace | Maryland | 21078 | — |
| Great Lakes Eye Care | Saint Joseph | Michigan | 49085 | — |
| Comprehensive Eye Care | St Louis | Missouri | 63090 | — |
| Ophthalmic Consultants of Long Island | Lynbrook | New York | 11563 | — |
| Rochester Ophthalmological Group | Rochester | New York | 14618 | — |
| Charlotte Eye Ear Nose & Throat Associates, P.A. | Belmont | North Carolina | 28012 | — |
| Michael E. Tepedino, M.D. | High Point | North Carolina | 27262 | — |
| The Eye Institute | Tulsa | Oklahoma | 74104 | — |
| Texan Eye | Austin | Texas | 78731 | — |
| Glaucoma Associates of Texas - Dallas Office | Dallas | Texas | 75231 | — |
| Cataract & Glaucoma Center | El Paso | Texas | 79902 | — |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78240 | — |
| Stacy R. Smith, M.D. | Salt Lake City | Utah | 84117 | — |
| Virginia Eye Consultants | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02057575, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2019 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02057575 live on ClinicalTrials.gov.